Dear Physicians, Anticoagulation in renal impairment requires careful agent selection. Test your knowledge on the safest, evidence-backed choice for AF patients with stage 3 CKD. ##Reference## Chang Y, et al.
Comparative effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin in patients with atrial fibrillation and chronic kidney disease. J Am Coll Cardiol. 2022;79(6):570-582.##
China Reports First Commercial Brain-Computer Interface Implant for Spinal Cord Injury
Anatomy & Physiology
1h ago
0
Rare Triple Procedure Addresses Breast Cancer and Silent Cardiac Disease in One Operation
Cardiology
1h ago
0
India Adds Nearly 10,000 MBBS Seats for 2026 to 2027 Academic Session
Allergy & Immunology
8h ago
112
Which Therapy Directly Targets the Pituitary in Cushing Disease?
Endocrinology
8h ago
155
Retina Clinic Visits Reveal Widespread Uncontrolled BP in Diabetes
Cardiology
11h ago
218
2
Prolonged Colchicine Therapy Linked to Lower Recurrence Risk in Young Adults With Acute Myocarditis
Cardiology
13h ago
260
1